Tapewire

Nasdaq · USD

OM

Outset Medical, Inc.

Export transactions ↓
Tapewire entity
7026
SEC CIK
0001484612
Parsed reports
379

Last 12 months

Inside the activity.

2 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202609
Feb 202603
Mar 202600
Apr 202600
May 202603
Jun 202601
Jul 202600
Aug 202603
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 17, 2025 Filed Jan 22, 2025 23:02 UTC
Ahmed NabeelChief Financial Officer
GrantCommon Stock 13,256 $0.00 $0.00
Disclosure

SEC source: 0001484612-25-000022 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,157

F1 · shares: On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period.

Read SEC document
January 13, 2025 Filed Jan 13, 2025 23:34 UTC
Brottem John L.General Counsel
SaleCommon Stock 20,492 $0.81 $16,598.52
Disclosure

SEC source: 0001484612-25-000014 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,028

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 13, 2025 Filed Jan 13, 2025 23:36 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 15,011 $0.81 $12,158.91
Disclosure

SEC source: 0001484612-25-000015 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,291

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 31,996 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 13, 2025 Filed Jan 13, 2025 23:51 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 33,227 $0.81 $26,913.87
Disclosure

SEC source: 0001484612-25-000016 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 861,397

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 70,826 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 13, 2025 Filed Jan 13, 2025 23:32 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 29,031 $0.81 $23,515.11
Disclosure

SEC source: 0001484612-25-000013 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,901

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 45,328 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 07, 2025 Filed Jan 8, 2025 00:26 UTC
Brottem John L.General Counsel
SaleCommon Stock 1,572 $1.29 $2,027.88
Disclosure

SEC source: 0001484612-25-000006 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,520

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,530 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 07, 2025 Filed Jan 8, 2025 00:32 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 10,227 $1.29 $13,192.83
Disclosure

SEC source: 0001484612-25-000008 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 894,624

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 22,469 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 07, 2025 Filed Jan 8, 2025 00:28 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 720 $1.29 $928.80
Disclosure

SEC source: 0001484612-25-000007 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,302

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,581 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
January 07, 2025 Filed Jan 8, 2025 00:24 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 1,835 $1.29 $2,367.15
Disclosure

SEC source: 0001484612-25-000005 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,932

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 2,952 shares of Common Stock underlying PSUs which (i) were, as previously reported, originally earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (ii) vested and were released on January 6, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 15, 2024 Filed Nov 18, 2024 22:45 UTC
Brottem John L.General Counsel
SaleCommon Stock 3,203 $0.80 $2,562.40
Disclosure

SEC source: 0001484612-24-000072 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 227,092

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,888 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 15, 2024 Filed Nov 18, 2024 22:49 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 5,645 $0.80 $4,516.00
Disclosure

SEC source: 0001484612-24-000074 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 904,851

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,740 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 15, 2024 Filed Nov 18, 2024 22:48 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 1,375 $0.80 $1,100.00
Disclosure

SEC source: 0001484612-24-000073 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,022

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
November 15, 2024 Filed Nov 18, 2024 22:44 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 4,221 $0.80 $3,376.80
Disclosure

SEC source: 0001484612-24-000071 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,767

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 15, 2024 Filed Aug 15, 2024 23:59 UTC
Brottem John L.General Counsel
SaleCommon Stock 3,011 $0.84 $2,529.24
Disclosure

SEC source: 0001484612-24-000064 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,295

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 00:02 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 5,308 $0.84 $4,458.72
Disclosure

SEC source: 0001484612-24-000066 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 910,496

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,740 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 15, 2024 Filed Aug 16, 2024 00:01 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 1,293 $0.84 $1,086.12
Disclosure

SEC source: 0001484612-24-000065 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239,397

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,584 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, March 15, 2023, and July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
August 15, 2024 Filed Aug 15, 2024 23:57 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 3,971 $0.84 $3,335.64
Disclosure

SEC source: 0001484612-24-000063 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,988

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
July 24, 2024 Filed Jul 24, 2024 23:08 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 723 $4.02 $2,906.46
Disclosure

SEC source: 0000905148-24-001998 · form4.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,690

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,999 shares of Common Stock underlying RSUs granted to the reporting person on July 24, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:17 UTC
Brottem John L.General Counsel
SaleCommon Stock 10,569 $4.78 $50,519.82
Disclosure

SEC source: 0001484612-24-000058 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,306

F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $4.77 - $4.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 38,117 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · derivative · entry 7

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,117 shares

Expires 2024-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

F3 · derivative.exercise_date: This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 31,186 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · derivative · entry 6

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,117

Underlying: Common Stock · 31,186 shares

Expires 2024-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

F3 · derivative.exercise_date: This option vested 25% on April 15, 2015 and then in 36 equal monthly installments thereafter.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC SaleCommon Stock 11,887 $3.74 $44,468.08
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 4

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,035

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $3.66-$3.83. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC Exercise / conversionCommon Stock 38,117 $1.11 $42,309.87
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 3

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC SaleCommon Stock 26,230 $3.80 $99,765.81
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 2

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,805

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $3.66-$3.83. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 03, 2024 Filed Jun 3, 2024 22:57 UTC Exercise / conversionCommon Stock 31,186 $1.11 $34,616.46
Disclosure

SEC source: 0001484612-24-000057 · edgardoc.xml · nonDerivative · entry 1

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on August 7, 2023.

Read SEC document
May 29, 2024 Filed May 29, 2024 23:17 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000056 · edgardoc.xml · nonDerivative · entry 1

Saia Andrea Lynn · CIK 0001552993 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,892

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:16 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000055 · edgardoc.xml · nonDerivative · entry 1

LANG BRENT D. · CIK 0001544336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,024

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:15 UTC
JONES DALE EDirector
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000054 · edgardoc.xml · nonDerivative · entry 1

JONES DALE E · CIK 0001261562 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,918

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:11 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000053 · edgardoc.xml · nonDerivative · entry 1

Hinrichs James F. · CIK 0001506974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,349

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:06 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000051 · edgardoc.xml · nonDerivative · entry 1

GROSSMAN D KEITH · CIK 0001218702 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,849

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:05 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000050 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,232

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 29, 2024 Filed May 29, 2024 23:10 UTC GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000052 · edgardoc.xml · nonDerivative · entry 1

HACKETT PATRICK T · CIK 0001238606 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,849

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Read SEC document
May 16, 2024 Filed May 17, 2024 21:36 UTC
Brottem John L.General Counsel
SaleCommon Stock 2,972 $3.53 $10,491.16
Disclosure

SEC source: 0001484612-24-000047 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,875

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,887 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Read SEC document
May 16, 2024 Filed May 17, 2024 21:40 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 3,918 $3.53 $13,830.54
Disclosure

SEC source: 0001484612-24-000049 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,959

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,761 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, August 5, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
May 16, 2024 Filed May 17, 2024 21:38 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 1,097 $3.53 $3,872.41
Disclosure

SEC source: 0001484612-24-000048 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,413

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 3,084 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021, March 15, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
May 16, 2024 Filed May 17, 2024 21:25 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 5,237 $3.53 $18,486.61
Disclosure

SEC source: 0001484612-24-000046 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 915,804

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,739 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022, and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Read SEC document
May 10, 2024 Filed May 10, 2024 22:19 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 8,306 $3.27 $27,160.62
Disclosure

SEC source: 0001484612-24-000041 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,325

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Read SEC document
March 15, 2024 Filed Mar 15, 2024 22:40 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 2,391 $2.13 $5,092.83
Disclosure

SEC source: 0001484612-24-000039 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,510

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,399 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Read SEC document
March 12, 2024 Filed Mar 13, 2024 20:56 UTC GrantCommon Stock 108,024 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000037 · edgardoc.xml · nonDerivative · entry 1

LANG BRENT D. · CIK 0001544336 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,024

F1 · shares: Represents Restricted Stock Units ("RSUs") granted to the reporting person on March 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest quarterly over three years, subject to the reporting person's continued service through the applicable vesting date.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 21:34 UTC
Ahmed NabeelChief Financial Officer
SaleCommon Stock 1,584 $3.15 $4,989.60
Disclosure

SEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 2

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 322,877

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 17, 2023.

Read SEC document
February 29, 2024 Filed Mar 4, 2024 21:34 UTC
Ahmed NabeelChief Financial Officer
OtherCommon Stock 1,584 $2.68 $4,245.12
Disclosure

SEC source: 0001484612-24-000036 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 324,461

F1 · balance_after: Includes 1,584 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Read SEC document
February 23, 2024 Filed Feb 26, 2024 21:05 UTC
Ahmed NabeelChief Financial Officer
Tax withholdingCommon Stock 10,639 $3.72 $39,577.08
Disclosure

SEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 2

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,877

F2 · shares: Required number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs on February 23, 2024 described in footnote (1) above. This transaction does not represent a sale or discretionary trade by the reporting person.

Read SEC document
February 23, 2024 Filed Feb 26, 2024 21:05 UTC
Ahmed NabeelChief Financial Officer
GrantCommon Stock 20,922 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000035 · edgardoc.xml · nonDerivative · entry 1

Ahmed Nabeel · CIK 0001870610 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,516

F1 · shares: Represents restricted stock units (RSUs) granted to the reporting person on February 23, 2024 in lieu of 50% of the reporting person's 2023 annual cash bonus amount at the request of the reporting person. The RSUs were fully vested on the grant date.

Read SEC document
February 23, 2024 Filed Feb 26, 2024 21:04 UTC
Trigg LeslieDirector · Chair and CEO
Tax withholdingCommon Stock 45,538 $3.72 $169,401.36
Disclosure

SEC source: 0001484612-24-000034 · edgardoc.xml · nonDerivative · entry 2

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 919,240

F2 · shares: Required number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs on February 23, 2024 described in footnote (1) above. This transaction does not represent a sale or discretionary trade by the reporting person.

Read SEC document
February 23, 2024 Filed Feb 26, 2024 21:04 UTC
Trigg LeslieDirector · Chair and CEO
GrantCommon Stock 131,687 $0.00 $0.00
Disclosure

SEC source: 0001484612-24-000034 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 964,778

F1 · shares: Represents restricted stock units (RSUs) granted to the reporting person on February 23, 2024 in lieu of 100% of the reporting person's 2023 annual cash bonus amount at the request of the reporting person. The RSUs were fully vested on the grant date.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:26 UTC
Brottem John L.General Counsel
SaleCommon Stock 3,341 $3.57 $11,927.37
Disclosure

SEC source: 0001484612-24-000028 · edgardoc.xml · nonDerivative · entry 1

Brottem John L. · CIK 0001823381 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,046

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 5,891 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:31 UTC
Williamson Steven S.Chief Commercial Officer
SaleCommon Stock 2,500 $3.57 $8,925.00
Disclosure

SEC source: 0001484612-24-000032 · edgardoc.xml · nonDerivative · entry 1

Williamson Steven S. · CIK 0001478582 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,347

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 7,677 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:29 UTC
Trigg LeslieDirector · Chair and CEO
SaleCommon Stock 5,320 $3.57 $18,992.40
Disclosure

SEC source: 0001484612-24-000031 · edgardoc.xml · nonDerivative · entry 1

Trigg Leslie · CIK 0001304125 · Director · Chair and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 833,091

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 14,748 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:28 UTC
Racine Jean-OlivierChief Technology Officer
SaleCommon Stock 1,866 $3.57 $6,661.62
Disclosure

SEC source: 0001484612-24-000030 · edgardoc.xml · nonDerivative · entry 1

Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,830

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,210 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
February 15, 2024 Filed Feb 16, 2024 22:27 UTC
Nash MarcSVP Operations and R&D
SaleCommon Stock 617 $3.57 $2,202.69
Disclosure

SEC source: 0001484612-24-000029 · edgardoc.xml · nonDerivative · entry 1

Nash Marc · CIK 0001983815 · SVP Operations and R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,100

F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 1,484 shares of Common Stock underlying RSUs granted to the reporting person on March 8, 2021, March 15, 2021 and March 15, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.